Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Blood Thinner From Pfizer, Bristol-Myers Blocks Leg Clots
Bloomberg
Sunday, December 9, 2012 - 11:22am
tags:
Bristol-Myers Squibb, Pfizer, Eliquis, blood thinners, anticoagulants
This Metric Says You're Smart to Own Impax Laboratories
Motley Fool
Saturday, December 8, 2012 - 11:37am
tags:
Impax Laboratories
EU Upholds $63 Million Fine for AstraZeneca
Courthouse News Service
Saturday, December 8, 2012 - 11:34am
tags:
AstraZeneca, legal, fines
This Top Big Pharma Stock Just Got an Upgrade
Motley Fool
Saturday, December 8, 2012 - 11:31am
tags:
Novo Nordisk
This Blockbuster Drug Gets a Green Light
Motley Fool
Saturday, December 8, 2012 - 11:31am
tags:
Bristol-Myers Squibb, arthritis, Orencia
Another Big Pharma Goes After Alzheimer's
Motley Fool
Saturday, December 8, 2012 - 11:29am
tags:
Alzheimer's disease, MK-8931, Merck
This Undervalued Pharma Is Ready To Move Higher
Motley Fool
Saturday, December 8, 2012 - 11:28am
tags:
AstraZeneca, type 2 diabetes, Forixga, Dapagliflozin
Zogenix Painkiller Fails to Win Support of U.S. Advisers
Bloomberg
Saturday, December 8, 2012 - 11:27am
tags:
Zogenix, Zohydro, pain management
AbbVie's Life After Abbott
Motley Fool
Saturday, December 8, 2012 - 11:25am
tags:
AbbVie, Abbott Laboratories
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Yahoo/PR Newswire
Saturday, December 8, 2012 - 11:23am
tags:
Halozyme, Roche, rituxumab, MabThera
Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemoglobinopathies at 54th American Society of Hematology (ASH) Annual Meeting
Yahoo/BusinessWire
Saturday, December 8, 2012 - 11:18am
tags:
Alnylam, β-thalassemia
Invest in the Great Progress of Hepatitis C
Motley Fool
Saturday, December 8, 2012 - 11:17am
tags:
hepatitis C, Gilead Sciences, sofosbuvir, Medivir, TMC435, ACH-1625, Achillion
Pharmacyclics Blood-Cancer Drug Controls Disease in Study
Bloomberg
Saturday, December 8, 2012 - 11:06am
tags:
chronic lymphocytic leukemia, ibrutinib, Pharmacyclics
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
Seeking Alpha
Saturday, December 8, 2012 - 11:04am
tags:
Gilead Sciences, hepatitis C, sofosbuvir
SAC Capital’s InterMune Trades Said to Be Probed by FBI
Bloomberg
Saturday, December 8, 2012 - 11:03am
tags:
InterMune
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, December 8, 2012 - 11:02am
tags:
Geron, Amarin, Acadia
Analyst Debate: Is Arena Pharmaceuticals a Top Stock?
Motley Fool
Saturday, December 8, 2012 - 11:01am
tags:
Arena Pharmaceuticals, Belviq, weight loss, obesity
Pain Therapeutics Declares Special One-Time Cash Distribution to Shareholders
Yahoo/GlobeNewsWire
Saturday, December 8, 2012 - 11:00am
tags:
Pain Therapeutics
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, December 8, 2012 - 11:00am
tags:
Hi-Tech Pharmacal, Aetna, Dendreon
Galena Presents Data, Sarepta Updates Study: Healthcare Business Wrap
Wall Street Cheat Street
Saturday, December 8, 2012 - 10:57am
tags:
Sarepta Therapeutics, Galena Biopharma, Abiomed, CombiMatrix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.